Skip to content

Understanding Prakriti and Its Role in Ekakustha (Plaque Psoriasis) and Its Management with Ayurvedic Polyherbal Medicine.

STUDY ON PRAKRITI WITH SPECIAL REFERENCE TO IMPACT OF DAIHIK PRAKRITI IN PATIENT WITH EKAKUSTHA (PLAQUE PSORIASIS) AND IT S MANAGEMENT WITH POLYHERBAL FORMULATIONS IN AYURVEDA. - NILL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101494
Enrollment
60
Registered
2026-01-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

None listed

Sponsors

Institute Of Post Graduate Ayurvedic Education And Research At SVSP Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients with diagnosis of mild to moderate psoriasis or new OPD patient with skin disorder having clinical feature of plaque psoriasis 2 Psoriasis Area and Severity Index PASI less than 30 percent 3 Body Surface Area BSA less than 10 percent

Exclusion criteria

Exclusion criteria: 1 Patient with cardiac failure, congenital heart disease renal failure diabetes hypertension severe organic disease 2 Pregnant lady and lactating mother 3 Abuse of alcohol and drugs 4 Acute progressive psoriasis and erythroderma tendency 5 Patient treated with corticosteroid and immunosuppressive drugs during last 4 weeks

Design outcomes

Primary

MeasureTime frame
Evaluation of the effect of polyherbal Ayurvedic Kasaya and Aragvadh Tail on Ekakustha (plaque psoriasis) patient.Timepoint: 12 Weeks

Secondary

MeasureTime frame
Evaluation of impact of Prakriti on individual with Ekakustha (plaque psoriasis).Timepoint: 12 Weeks

Countries

India

Contacts

Public ContactAKASH PANDEY

INSTITUTE OF POST GRADUATE AYURVEDIC EDUCATION AND RESEARCH AT SHYAMADAS VAIDYA SHASTRA PITH.

drpartha264@gmail.com9433725917

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026